Skip to main content
. 2013 Dec 30;7:280. doi: 10.1186/1752-1947-7-280

Table 2.

Adverse events related to rituximab administration

Timing of rituximab administration Number of patients who suffered from infusion reactions Number of patients who had no infusion reactions Total number of patients
With the first course of chemotherapy
14
15
29
With or after the second course of chemotherapy 4 23 27